(WHO) issued a global alert describing cases of atypical pneumonia of unknown cause appearing in Hong Kong, China, and Vietnam. 1 As of April 28, 2003, severe acute respiratory syndrome (SARS) has been described in 28 countries involving 5050 individuals Early Release: This article as posted online at http:// www.jama.com on May 6, 2003. Author Affiliations are listed at the end of this article.

T he scientific, academic, medical and data science communities have come together in the face of the COVID-19 pandemic crisis to rapidly assess novel paradigms in artificial intelligence (AI) that are rapid and secure, and potentially incentivize data sharing and model training and testing without the usual privacy and data ownership hurdles of conventional collaborations 1,2 . Healthcare providers, researchers and industry have pivoted their focus to address unmet and critical clinical needs created by the crisis, with remarkable results [3][4][5][6][7][8][9] . Clinical trial recruitment has been expedited and facilitated by national regulatory bodies and an international cooperative spirit 10-12 . The data analytics and AI disciplines have always fostered open